The present invention encompasses influenza vaccines, in particular canineinfluenza vaccines. The vaccine may be a recombinant poxvirus vaccine or aninactivated vaccine. The invention also encompasses recombinant poxvirusvectors encoding and expressing influenza antigens, epitopes or immunogenswhich can be used to protect animals, in particular dogs, against influenza.